| Antibiotic resistance in Pseudomonas aeruginosa and alternative therapeutic options M Chatterjee, CP Anju, L Biswas, VA Kumar, CG Mohan, R Biswas International Journal of Medical Microbiology 306 (1), 48-58, 2016 | 364 | 2016 |
| Understanding the Structure–Function Relationship of Lysozyme Resistance in Staphylococcus aureus by Peptidoglycan O-Acetylation Using Molecular Docking … AC Pushkaran, N Nataraj, N Nair, F Götz, R Biswas, CG Mohan Journal of chemical information and modeling 55 (4), 760-770, 2015 | 85 | 2015 |
| Preparation, characterization and efficacy of lysostaphin-chitosan gel against Staphylococcus aureus S Nithya, TR Nimal, G Baranwal, MK Suresh, CP Anju, VA Kumar, ... International Journal of Biological Macromolecules 110, 157-166, 2018 | 46 | 2018 |
| Combination of repurposed drug diosmin with amoxicillin-clavulanic acid causes synergistic inhibition of mycobacterial growth AC Pushkaran, V Vinod, M Vanuopadath, SS Nair, SV Nair, ... Scientific reports 9 (1), 6800, 2019 | 43 | 2019 |
| Bacterial peptidoglycan with amidated meso-diaminopimelic acid evades NOD1 recognition: an insight into NOD1 structure–recognition S Vijayrajratnam, AC Pushkaran, A Balakrishnan, AK Vasudevan, ... Biochemical Journal 473 (24), 4573-4592, 2016 | 41 | 2016 |
| Understanding the adhesion mechanism of a mucin binding domain from Lactobacillus fermentum and its role in enteropathogen exclusion M Chatterjee, AC Pushkaran, AK Vasudevan, KKN Menon, R Biswas, ... International journal of biological macromolecules 110, 598-607, 2018 | 39 | 2018 |
| A phytochemical-based medication search for the SARS-CoV-2 infection by molecular docking models towards spike glycoproteins and main proteases AC Pushkaran, AR Melge, R Puthiyedath, CG Mohan RSC advances 11 (20), 12003-12014, 2021 | 19 | 2021 |
| Multiple e-Pharmacophore modeling to identify a single molecule that could target both streptomycin and paromomycin binding sites for 30S ribosomal subunit inhibition A CP, S Subhramanian, N Sizochenko, AR Melge, J Leszczynski, ... Journal of Biomolecular Structure and Dynamics 37 (6), 1582-1596, 2019 | 14 | 2019 |
| Understanding the molecular differential recognition of muramyl peptide ligands by LRR domains of human NOD receptors S Vijayrajratnam, AC Pushkaran, A Balakrishnan, AK Vasudevan, ... Biochemical Journal 474 (16), 2691-2711, 2017 | 14 | 2017 |
| Interaction mechanism of Mycobacterium tuberculosis GroEL2 protein with macrophage Lectin-like, oxidized low-density lipoprotein receptor-1: an integrated computational and … V Vinod, AC Pushkaran, A Kumar, CG Mohan, R Biswas Biochimica et Biophysica Acta (BBA)-General Subjects 1865 (1), 129758, 2021 | 9 | 2021 |
| Chemical modifications of cinchona alkaloids lead to enhanced inhibition of human butyrylcholinesterase D Karlsson, A Fallarero, P Shinde, CP Anju, I Busygin, R Leino, ... Natural Product Communications 9 (4), 1934578X1400900404, 2014 | 6 | 2014 |
| De Novo designing of HDAC inhibitors in cancer therapy CP Anju, NJ Anusooya, M Deeasree, OM Deepak, PKK Namboori International Journal of Pharmaceutical Science and Health Care 2, 59-66, 2012 | 6 | 2012 |
| Identification of a PD1/PD‐L1 inhibitor by structure‐based pharmacophore modelling, virtual screening, molecular docking and biological evaluation A Choorakottayil Pushkaran, K K, R Biswas, CG Mohan Molecular Informatics 42 (6), 2200254, 2023 | 4 | 2023 |
| Impact of Target-Based Drug Design in Anti-bacterial Drug Discovery for the Treatment of Tuberculosis AC Pushkaran, R Biswas, CG Mohan Structural Bioinformatics: Applications in Preclinical Drug Discovery …, 2019 | 3 | 2019 |
| From understanding diseases to drug design: can artificial intelligence bridge the gap? AC Pushkaran, AA Arabi Artificial Intelligence Review 57 (4), 86, 2024 | 1 | 2024 |
| BMPR2 mutation and clinical response to imatinib in a case of heritable pulmonary arterial hypertension S Kumar, L Biswas, AC Pushkaran, RK Kumar Pulmonary Circulation 14 (1), e12335, 2024 | | 2024 |
| P., Melge AR, Puthiyedath R., Mohan CG A phytochemical-based medication search for the SARS-CoV-2 infection by molecular docking models towards spike glycoproteins and main … AC Pushkaran, EN Nath RSC Advances 11 (20), 12003-12014, 2021 | | 2021 |
| Structure-based bioactive phytochemical design from Ayurvedic formulations towards Spike and Mpro druggable targets of SARS-CoV-2 AC Pushkaran, SV Nair, P Rammanohar, CG Mohan | | 2020 |
| Antibiotic resistance in Pseudomonas aeruginosa and alternative therapeutic options. MC Maitrayee Chatterjee, CP Anju, L Biswas, VA Kumar, CG Mohan, ... | | 2016 |
